The epidermal growth factor receptor (EGFR) and its downstream signaling pathways, including the RAS-RAF-MAPK and phosphatidylinositol 3-kinase (PI3K)-Akt pathways, play important roles in tumor growth in CRC [2]. The gene discussed is EGFR; the disease is neoplasm.